Member Info for roger65

personally i think they will try to get one of the IPOs done before releasing the MFC results. PJ put his reputation on the line with the number of times he mentioned 'massive sulphides' and the potential for 'transformational' results. the recent RNS which stated the results would definitely help increase POW's 'understanding' of the geological area was a bit of a clue...No hint that it might increase the value of the company. Tucked these away now for a rainy day. It's a good portfolio and now in different hands I would not be surprised ( and am hoping) to see the focus switch to the Uranium and Tungsten interests. Price of Gold anywhere near $2k per oz also means Tati may have some near term potential to do well.

for now though just gotta be patient.

Thanks for that post MyIPA. If the daily churn continues like today that will help matters. We also need the mms to not get involved the way they sometimes do ie moving the sp up/down a lot on low volume.

Many factors at play. We need sales.

Budd gets a £300k pa salary but is asking us to risk our investment in GDR by voting for this deal. Yes, he's told us it was the best deal they could get, all things considered. I for one will be furious if we hear nothing from him now for the next two or three months. He needs our approval for this deal to get through so I'd suggest he does what was promised after the last AGM, at which the number of votes cast against his reappointment were high (relative to the number who actually voted), and open lines of communication with share holders and help generate positive sentiment. You've got us all into shark infested waters with Riverfort. Now provide us with some means to stop them from gobbling us up or risk not getting this deal voted through. My guess is the sp will remain stable until this deal gets through and then the real games will begin.

If we get news of sales all will be well but NHS will be within the next few months and FDA is now way down the track. Where are the sales we so badly need be coming from Mr Budd?

Starres - Hopefully it won't be long before NICE do give it that stamp of approval but I've no idea when that might be or which processes AIHL needs to go through in order to achieve it. I think (nto 100% sure though) that having that would mean all NHS Trusts would MUST adopt the machines and offer the tests to all parents of newborns who find themselves in the unfortunate position of needing one.

Brighty - you are right about Gilham. I looked him up too and this is exactly what he does. Actually now that Riverfort are involved I see a Takeover even more likely than before. If things go pear shaped then GDR will be snatched up for peanuts but...if Budd can get that positive news flow out in good time then things will quickly escalate and a corporate may make their move sooner than some might expect.

As long as Budd can announce sales soon we should be ok but it's a nervy time for holders here. If some don't feel that way that's fine, I'm not trying to persuade people that's how they should feel!

FDA news is some way off, as announced, and the next 7 NHS Hospitals to adopt AIHL will be up and running in the next few months, also as announced. Also as announced there are still some regulatory approvals needed for us to register with some of the Distributors we have agreements with so I'm not expecting huge sales in those other territories overnight. Some however were set up quite a while ago (Austria) and so we might begin to see a trickle of sales. Anything would be good to be told about. We'll hover now between 28 - 32p until the next news. If that takes months to arrive then imho I don't expect the sp to get anywhere near 40p anytime soon.

What the market and lths DON'T need is another few months of silence Mr Budd! Keep the news flow going.

This finance deal isn't great but I acknowledge it isn't awful either, as long as we generate income soon. It's just a shame that we were told (by Budd himself - if you believe it was him) it was the best available once all things were considered. I'm now hoping Riverfort will be happy to see how things go rather than actively transpire to damage the company. They will make money if GDR succeeds so we all just have to hope they're content to sit on the fence for the next few months and give GDR a chance to prove it can sell its products.

I am invested (heavily) and not seeking to disrupt and I am sorry if my knee-jerk post on Saturday unsettled some. Not achieving 'Best Practise' from NICE was a blow having thought it was nailed on. The products are great. We simply MUST get them off the shelves and into hospitals soon though!

found this line in the first of 'the real David Budd's posts....totally believable. lol

'A few well informed and well considered posters on here, and a few absolute nutters apparently too, but you know that already.'

Oh he also said he'd only be posting once. he's now posted three times. Hope everyone enjoys the 'daily liquidly' next week.

Well, if this week the sp flies or even goes up a little I'll happily sit back and watch from the sidelines from now on and stop posting. The number of green boxes and 'he said....you said...' posts mean the board is at times too painful to read anyway.

Good luck to genuine holders. And just for the record I absolutely 100% do not believe the post is written by the real David Budd. I would be honestly dismayed if I thought the CEO of any company I was invested in, even one on AIM, took any notice or time to read all the nonsense one finds on here.

Sorry Nissan but your uber positive posts are well wide of the mark here imho

Make no mistake, this IS death spiral financing and, whilst the terms are not too onerous, Riverfort will have already had their pound of flesh since January and will now want more. They will care not one jot if GDR survives or not. Since January there has been massive buying of shares and more recently massive selling of shares. Do you really think that's all been down to pis? No, I think it's down Riverfort and this deal will have been several months in the planning and they're already now on a free run with GDR. Budd said they tried to do a traditional placing and couldn't manage it.

I'm scratching my head when I read posters thanking Budd. He has put GDR on more of a knife edge than ever! FDA news, as stated in the RNS, is clearly some way off so quoting the market figures for that are pointless for now. GDR needs revenue FAST. Think about what happens if the sp drops to say 20p. Do people here think Riverfort then lose out? I'm afraid not. The terms can change according the 5 day VWAP and mda and numerous other factors, all of which are in Riverfort's favour . Once you get under the surface it makes for extremely uncomfortable reading.

Everything now depends on selling and this is why I'm feeling pretty miserable. GDR had Beckman Coulter as a distributor for the COVID PoC kit. They sold nothing. Distributors are all well and good but unless there are announcements of sales this week then the sp is going to slide, not go up. GDR have NO track record of being able to sell anything.

Nissan you keep quoting figures the GDR sp managed when the pandemic was in full flow. Those crazy spikes happened because there were hundreds of millions of people that could have taken the GDR test, not just once a year but perhaps several times a month. FDA rejected it and our various distributors couldn't sell any meaningful numbers - £50k in 6 months was the best they managed.

AIHL has a potential market in the UK of £8m per year. That's IF and only if every single newborn taken into special neo-natal care units takes the test. To get to that scenario could take years. NICE did not recommend BEST PRACTISE. Without the US market the global figures total about £70m per year so let's be conservative and say GDR achieve 25% sales of that. That would suffice but they would need to achieve those sales fast in order to provide support to the sp this very week.

The market and pros are no fools and will know this is hugely risky now, more so than ever. Budd, unless he knows full well he has sales contracts to announce next week, has stitched lths up here well and truly. Not deliberately of course but, due to woeful performance in the commercial arena to date, there is simply no confidence from any other possible funding avenues.

The RNS was released after hours on a Friday. Why? Think I know now.

what a crap day. Interims followed by another 20% drop? Then announce a placing at a discount of 40%? I honestly wouldn't put it past Budd.

Stroke Marker Test is now the next big hope as clearly the wider market has no confidence in GDR's ability to sell anything. Back to my already overcrowded bottom drawer!

'build onto the next phase of news and updates and really start to push this closer to the £.'

the time to start doing that is right now whilst GDR is in the news. Got a feeling budd won't fail to let us down though and let the moment pass us by...

FDA news. Stroke Marker Test, NHS adoption of AIHL tests, news of any sales in other territories outside the UK or in the private sector. Anything other than sticking his head back down in the sand.

News of another installation somewhere would help right now. come on VDTK, you know you want to...

i mean they will try to embrace it alongside fiat currency. that way they retain their controls/influence whilst not risking being left out if crypto suddenly really takes off. Crypto can make serious money and therefore banks and Govts will want to be in on it rather than suppress it altogether. Yes, that will mean more regulation but if that means crypto can become more mainstream so much the better.

As for ARB, why hasn't a new CEO been found yet? Is no one willing to take it on?

....'whilst the test is being used ROUTINELY within NHS sites'

That means money rolling into GDR's bank account over the several years they are gathering data. All good.

Budd needs to do something!! Just sitting with his head in the sand yet again will achieve nothing for GDR.

An easy comm via Twitter would help restore a little confidence and see positive sentiment return in spades.

Will he say anything though? hmmm News of any other NHS Trusts planning to use AIHL would be good David. Anything positive on the FDA pre-submission discussions would be good David. Reassurance regarding funding would be very good David. Anything positive to say on the Stroke Marker Tests would be good David. Come on. DO or SAY something to help the markets understand the massive potential here right now.

Disagree. Think they will begin to embrace it as an insurance against failure of fiat currency. bwtfdik

Brighty - I'm here for a takeover in the hundreds of millions....

Me too. It's going to happen. If anyone looks at the Chairman's history you'll see that's his game.

history tells us that regardless of how good and unique GDR products are, even if they get to market as AIHL has, the CEO and sales team at GDR are totally crap. Budd has no scooby as to how to attract investment into the company or work the market in terms of the comms he puts out. To begin with he massively overhyped the Covid PoC kit which saw the sp shoot up to over £2 and now, clearly having been reprimanded, he says the absolute bare minimum he can get away with.

GDR's tests will sell but will happen more slowly than we'd all like thanks to incompetence from half the GDR team. The scientists are fab whilst the business side of the team are sh.te. Gilham is a wily old fox from the research I've done and he has a history of overseeing massive drops in the sp of a company he takes on and then over a period of time they are dressed up and sold on for a good profit....BUT only a profit for those who bought in on the dips. I see that time for buying in as now. I firmly believe GDR will be sold but owing to Budd being a non-starter as a businessman and failure to see GDR properly valued in the financial markets I think the price eventually achieved will be lower than fair value. That said, once AIHL and the stroke marker tests are being sold via distributors globally I think Gilham will get this off his hands for about £1.57. There, I've nailed my colours to the mast. Furthermore I see this being sold as soon as it is known AIHL can be sold in the US. That could be six months or twelve but I don't think it will take longer than that if sales in the UK and EU start to build well.

no problem at 33.05p. That tells me there are big buyers lurking happily snapping up shares here.

Yes Carlos, my point exactly. But this is where Budd and Gilham have let us down so many times before. They don't hive a sh/t about the sp.

I have a slight feeling at the back of my mind that the BODs might already have a buyer lined up though for GDR or else they would have already sorted the funding issue out already. Why leave it so late in the day when they know they will be running out of cash in the next 12 weeks or so? Time limits will only push them into a corner with any potential funders so perhaps they are already speaking to someone and were just waiting for NICE recommendation to land.

day traders and short term nervous pis out whilst investors slowly and silently move in. Warren Buffett's wise words ringing in anyone's ears..?

Agree totally with Brighty1

Budd said 'we are appreciative' which suggests to me at least that they expected this. We will now see how 'on the money' Budd and Gilham are and whether or not they are truly aligned with share holders' interests here. Hopefully they knew this was going to be the outcome - which is absolutely good news - and that without 'best practise' the market might want more positive news such as FDA and Stroke marker test to either sustain or continue building momentum in the sp. If the sp pulls back and they then dump a raise on us we'll know for sure they are out of the depth as they could easily have done a raise three weeks ago when the sp was climbing fast towards 50p. Sentiment at that time was incredibly high and the sp would have recovered quickly. Now I'm not so sure as a raise will surely be at a discounted rate and my guess is they will want to raise more now because they know the NHS roll out will not be as quick as if we'd received 'Best practise'.

The RNS gave approval and recommendation and hopefully will lead to FDA news quickly and sales in the EU and RoW. the funding issue is the big issue now and can Budd and Gilham get it sorted without damaging sentiment or not. We'll know soon enough. I think they will have to get it sorted very soon.